Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 6, 2018
Update on Diabetic Nephropathy: Core Curriculum 2018Kausik Umanath, Julia B LewisAdvances in Chronic Kidney Disease|March 8, 2014
Optimizing blood pressure control in patients with nondiabetic glomerular diseaseKausik Umanath, Julia B Lewis, Jamie P DwyerExpert Review of Endocrinology & Metabolism|February 9, 2019
Ferric citrate: a novel phosphate-binding agentKausik Umanath, Robert Niecestro, Julia B Lewis, et al.Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2014
Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costsRoger Rodby, Kausik Umanath, Robert Niecestro, et al.Advances in Chronic Kidney Disease|August 6, 2017
Getting to the Heart of the Matter: Review of Treatment of Cardiorenal SyndromeKausik Umanath, Sitaramesh EmaniHemodialysis International. International Symposium on Home Hemodialysis|June 19, 2012
Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysisKausik Umanath, Mohammed Sika, Robert Niecestro, et al.Journal of Behavioral Medicine|May 12, 2016
Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end stage renal diseaseEbele M Umeukeje, Joseph R Merighi, Teri Browne, et al.Journal of Behavioral Medicine|January 10, 2019
Correction to: Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end-stage renal diseaseEbele M Umeukeje, Joseph R Merighi, Teri Browne, et al.Hemodialysis International. International Symposium on Home Hemodialysis|September 13, 2016
Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysisDiana Jalal, Molly McFadden, Jamie P Dwyer, et al.Frontiers in Cardiovascular Medicine|June 15, 2026
Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitorsKausik Umanath, Jamie P Dwyer, Robert J MentzPageof 10